Background: Slowly resolving pneumonia (SRP) poses early challenges for identification and medical expense for clinicians in intensive care units (ICUs); to date, the literature has been very limited in this regard. Methods: This was a retrospective and cohort-based study in the ICU of a university-affiliated hospital in Shanghai. Medical records of pneumonia patients in the ICU between April 2008 and February 2011were reviewed retrospectively to evaluate the risk factors for SRP. Results: In all, 106 pneumonia patients in the ICU were identified as immune-competent with a diagnosis of bacterial pneumonia. There were 62 (58.49%) patients who showed SRP and their radiographic infiltrations were completely resolved between 5 weeks and 8 weeks. Multivariate logistic regression analysis demonstrated that initial treatment with an inappropriate antibiotic, multilobar infiltration, and a high CURB-65 score were independent risk factors for SRP, with odds ratio (OR) values of 8.338 [95% confidence interval (CI) 2.117e32.848], 11.184 (95% CI 2.526e49.514), and 2.329 (95% CI 1.172e4.626), respectively. The length of the ICU stay in the SRP group was twice as long as that of the normally resolving pneumonia (NRP) group (62.27 AE 73.73 vs. 32.25 AE 23, p Z 0.002). The 28-day and 60-day mortality rates in the SRP group were 17.74% and 25.81%, respectively. In addition, the 60-day mortality rate was significantly higher in the SRP group than the NRP group (25.81% vs. 6.82%, respectively; p Z 0.012). Moreover, SRP was an independent risk factor for 60-day mortality (OR 5.687, 95% CI 1.334e24.240).
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Introduction
The unapparent resolution of pulmonary infiltrates in both nonresolving and slowly resolving pneumonia (SRP) poses diagnostic and treatment challenges for clinicians as a common consultation problem. 1, 2 Nonresolving pneumonia often represents a noninfectious process that mimics an infectious process. 3, 4 SRP is usually associated with host-or treatment-related factors. 5, 6 Advances in procedures used to diagnose pneumonia have led to a declining incidence of nonresolving pneumonia, while the incidence of SRP is definitely rising with multiple supporting methods. 7, 8 Kirtland and Winterbauer 9 first proposed a definition of SRP that referred to immune-competent patients who exhibited improved clinical symptoms with antibiotic therapy and chest radiographs with less than 50% clearing by 2 weeks or less than complete clearing at 4 weeks. 10 To date, the literature concerning the evaluation and treatment of SRP has been limited. Although the precise incidence of SRP is not well established, early studies reported that 25e67% of the pulmonary infiltration of pneumonia patients showed delayed resolution along with high mortality, 11 prolonged hospital stays, and high treatment costs. 8 Some studies on critically ill patients found that as many as 47% of pneumonia cases showed delayed resolution. 12 Due to its high incidence and poor outcome, the recognition and resolution of SRP in intensive care units (ICUs) deserve more attention from clinicians.
The objective of this study was to investigate the incidence, length of ICU stay, outcome, and risk factors associated with SRP in critically ill patients to promote the identification of high-risk patients.
Methods

Ethical statement
The extent of our involvement with participants was limited to the evaluation of radiographic resolution and analysis of the participants' clinical features. We promised to hold all the information of participants in a confidential manner. The study protocol and consent procedure with waiver of written consent was approved by the Shanghai Jiao Tong University School of Medicine and affiliated to the Ruijin Hospital Ethics Committee.
Study population
The study group was sampled from patients who were admitted to the ICU of a 1300-bed university-affiliated hospital with a diagnosis of pneumonia between April 2008 and February 2011. {Pneumonia was defined as a new or progressive infiltrate as seen on a chest radiograph or computed tomography (CT) scan along with a high clinical suspicion of pneumonia, defined by at least one of the following: fever (>38 C); leucopenia [< 4000 white blood cells (WBC)/mm 3 ] or leukocytosis (> 12,000 WBC/mm 3 ); altered mental status with no other recognized cause (for adults older than 70 years); and at least two of the following: (a) new onset of purulent sputum, change in characteristics of sputum, increased respiratory secretions, or increased suctioning requirements, (b) new onset or worsening cough, dyspnea, or increased ventilation demand.} The inclusion criteria included pneumonia patients who reached clinical stability due to treatment in the ICU with a complete resolution or resolution of infiltrate differentiated from chronic changes. [Clinical stability was defined as a temperature 37.8 C, a heart rate 100 beats/min, a respiratory rate 24 breaths/min, systolic blood pressure ! 90 mmHg, arterial oxygen saturation ! 90% or PaO 2 ! 60 mmHg in room air, the ability to maintain oral intake, and a normal mental status. 10 ] The exclusion criteria included patients with immunodepression, interstitial pneumonia, pulmonary tumor, pulmonary tuberculosis, influenza A virus subtype H1N1 or another respiratory tract virus, legionnaires pneumonia, mycoplasma pneumonia, chlamydia pneumonia, and acute respiratory distress syndrome. [Immunodepression was defined as a recent history of neutropenia (< 0.5 Â 10 9 neutrophils/L for 110 days); the receipt of an allogeneic stem cell transplant; the prolonged use of corticosteroids (a mean minimum dose of 0.3 mg of prednisone equivalent/kg/day for 13 weeks); treatment with another recognized T cell suppressant such as cyclosporine, tumor necrosis factor-alpha (TNF-a) blockers, specific monoclonal antibodies, or nucleoside analogs during the past 90 days; or inherited severe immunodeficiency (such as chronic granulomatous disease or severe combined immunodeficiency). 13 
]
Study methodology
Every eligible patient had pre-pneumonia radiography as basic radiographic data and a CT scan performed to identify pulmonary destruction and multilobar infiltration. Each pneumonia patient was evaluated once a week in the ICU by bedside X-ray examination or CT scan if possible until the pulmonary infiltrates were completely resolved or their radiological signs normalized to previous levels. Two specialized radiography colleagues who were blinded to clinical status evaluated the radiographic infiltrates. The patients with SRP reached clinical stability but exhibited either persistent pulmonary infiltrates 4 weeks after an initial pneumonia-like syndrome or demonstrated less than 50% clearing on chest radiographs taken 2 weeks after starting antibiotic therapy. The normally resolving pneumonia (NRP) cases were completely resolved or normalized to previous levels within 4 weeks.
In our ICU, we usually did the sputum or endotracheal aspiration culture weekly or twice a week if needed as a routine procedure. Each pneumonia patient was examined for Mycobacterium tuberculosis, influenza virus, or other atypical pathogen to rule out pulmonary tuberculosis (TB), H1N1, or other atypical pneumonia. We also performed a Gram stain on sputum or endotracheal aspiration, and measured procalcitonin (PCT) and C-reactive protein (CRP) to identify colonization or infection.
Data collection
We collected clinical data from the participants, including their sex, age, aspiration history, pulmonary radiography, underlying diseases, CURB-65 score (a severity score including confusion, uremia, respiratory rate, blood pressure and age), Acute Physiology And Chronic Health Evaluation (APACHE) II score, PCT level, CRP level, microorganism from sputum sample or endotracheal aspiration, antibiotic susceptibility test, anti-infection treatments, steroid applications, need for an artificial airway, time required for radiographic clearing, and 28-day and 60-day mortality rates.
Definitions of risk factors
Initial treatment with an inappropriate antibiotic was defined as the first administration of an antimicrobial agent to which at least one causative microorganism was resistant or the lack of antimicrobial therapy for a known causative pathogen. High-dose steroid application was defined as the application of more than 2 mg intravenous methylprednisolone/ kg/day for at least 14 days. 17, 18 The continued isolation of pathogen was defined as the elimination of the original pathogen from sputum cultures less than twice. 19 Delayed clinical stability referred to a pneumonia patient who required more than 6 days to reach clinical stability. 10 
Statistical analysis
SPSS software (version 17.0; SPSS Inc., Chicago, IL, USA) was used for data analysis. The qualitative variables were expressed as frequency (%), while the quantitative variables were expressed as the mean AE standard deviation (SD). The SRP group was compared with the NRP group using the c 2 test, the continuity correction c 2 inspection, or Fisher's exact test for the qualitative variables (sex, type of pneumonia, aspiration history, radiographic characteristics, underlying diseases, microorganism and antibiotic susceptibility test results, anti-infection treatments, steroid applications, need for an artificial airway, 28-day and 60-day mortality rates) and a t test for the quantitative variables (age, CURB-65 score, APACHE II score, PCT level, CRP level). The data without a normal distribution were analyzed by the rank sum test. Univariate and multivariate analyses were performed to determine the risk factors associated with SRP. The KaplaneMeier method was used for the survival function.
Results
Characteristics of the patients
There were 154 pneumonia patients admitted to the ICU between April 2008 and February 2011. A total of 106 pneumonia patients were eligible for inclusion in the study, and 62 pneumonia patients met the criteria for SRP, exhibiting radiographic infiltration that was completely resolved within 5e8 weeks. The incidence of SRP was 58.49% ( Fig. 1) . As part of our study methodology, we ruled out two cases of pulmonary tuberculosis and five cases of H1N1 influenza. We found that 90.9% of single-lobe pneumonia cases completely resolve in 4 weeks, while 56% of multilobar pneumonia cases required 5e8 weeks to completely resolve.
The demographic data including age, sex, and underlying diseases were equivalent for both the SRP group (n Z 62) and the NRP group (n Z 44). There were no differences in aspiration history (n Z 28) and mechanical ventilation (n Z 49) between the two groups. The radiographic study revealed no significant differences in the destruction of the pulmonary structure and pleural effusion between the two groups ( Table 1 
SRP group risk factors
A correlation analysis between quantitative variables such as age, the number of underlying diseases, PCT, CRP, the Figure 1 . The complete radiographic resolution time for the two groups. The green line shows that the radiographic infiltration in the normally resolving pneumonia (NRP) patients completely resolved within 4 weeks, while the slowly resolving pneumonia (SRP) patients (blue line) required 5e8 weeks for complete resolution.
CURB-65 score, the APACHE II score, and complete radiographic resolution time was performed. This analysis showed that the CURB-65 and APACHE II scores correlated with the radiographic resolution time. The correlation coefficients for the CURB-65 and APACHE II scores were 0.2432 (p Z 0.012) and 0.2259 (p Z 0.0199), respectively. The qualitative variables, which included central nervous system disease, chronic obstructive pulmonary disease, heart failure, diabetes mellitus, aspiration history, pulmonary structure, pleural effusion, multilobar infiltration, initial treatment with an inappropriate antibiotic, delayed clinical stability, continued isolation of pathogen, multidrugresistant bacteria, artificial airway, and the application of high-dose steroids, were statistically analyzed by a univariate analysis. The univariate analysis identified treatment with an inappropriate antibiotic, multilobar infiltration, the lack of microbiological eradication, delayed clinical stability, and the application of high-dose corticosteroids as risk factors for SRP ( Table 2 ).
The microbiology results and initial antibiotic use of all patients were summarized in Table 3 . There was no difference in the culture-negative rates between SRP and NRP groups (14.52% vs. 25%, p Z 0.17). There were no statistically significant differences in the bacterial species and drug susceptibility testing present in the SRP and NRP groups; however, multidrug-resistant bacteria appeared at a higher rate in the SRP group (59.09%).The incidence of inappropriate initial antibiotic use in the entire study population was 27.36%dthis was evident by the value in the SRP group that was fourfold higher than that of the NRP group (p Z 0.0004). The multivariate logistic regression analysis demonstrated that treatment with an inappropriate antibiotic, multilobar infiltration, and high CURB-65 score were independent risk factors for SRP (Table 4) .
Prognosis and survey
The length of the ICU stay for the SRP group was twofold longer than that of the NRP group (62.27 AE 73.73 vs. 32.25 AE 23, p Z 0.002). The 28-day and 60-day mortality rates in the SRP group were 17.74% and 25.81%, respectively. In addition, the 60-day mortality rate was significantly higher in the SRP group than the NRP group (25.81% vs. 6.82%, respectively; p Z 0.012) (Fig. 2) . The multivariate logistic regression analysis showed that SRP was an independent risk factor for 60-day mortality [odds ratio (OR) 5.687, 95% confidence interval (CI) 1.334e24.240].
Discussion
SRP exhibits a high incidence in critically ill patients and causes prolonged ICU stays and expensive medical costs. Our study showed that the presence of SRP is an independent risk factor for 60-day mortality in the ICU. It is unlikely that this definition could be used clinically to diagnose patients with SRP at an early time point. Therefore, further investigation is required to identify the risk factors for SRP for early identification. From a list of possible factors including host-related factors, pulmonary radiographic features, microorganism characteristics, and treatmentrelated factors, 8, 11, 20, 21 our study suggested that the extent of pulmonary infiltration, pneumonia severity, and initial antibiotic therapy have important effects on the resolution of pneumonia in critically ill patients.
We found that 90.9% of single-lobe pneumonia cases completely resolve in 4 weeks, while 56% of multilobar pneumonia cases require 5e8 weeks to completely resolve as demonstrated in a Pneumococcus pneumonia study. 22 However, several previous studies in heterogeneous populations have suggested that the extent of pulmonary infiltration has an impact on pneumonia resolution. 22, 23 In critically ill patients, our study showed that the incidence of multilobar infiltration is much higher in the SRP group than the NRP group and is an independent risk factor for SRP. Therefore, we recommend that pneumonia cases in the ICU receive an immediate radiographic evaluation to determine the extent of infiltration and assess the possibility of SRP.
Both the extent of pulmonary infiltration and pneumonia severity had an impact on SRP. Several disease severity indicators are used in the ICU, including CURB-65 scores, 24 APACHE II scores, and biomarkers such as PCT and CRP. Current studies suggest that advanced age, a fast respiratory rate, low blood pressure, and underlying diseases are risk factors for SRP. 21 The CURB-65 score is a synthetic index that includes age, confusion, uremia, respiratory rate, and blood pressure. Our study showed that the CURB-65 score instead of the APACHE II score was not only positively correlated with pneumonia resolution time but also an independent risk factor for SRP.
Some studies suggested that PCT and CRP levels could indicate pneumonia severity. 25, 26 One study showed that a high CRP level was independently associated with the delayed resolution of radiographic abnormalities, 12 while Huang et al 26 showed that the PCT level provided little additional information over the CURB-65 score. Our results reflected no differences in the CRP levels of the SRP and NRP groups, whereas the PCT level was higher in the SRP group. However, our study further suggested that the CURB-65 score alone was an independent risk factor for SRP as a pneumonia severity indicator.
SRP was associated with both host-related factors and treatment-related factors. Treatment with an appropriate antibiotic plays an important role in pneumonia resolution. 19, 27 A few reports have shown that the incidence of inappropriate antibiotic therapy was high in pneumonia patients, especially in ventilator-associated pneumonia patients (50%) in the ICU. 28 We found the incidence of inappropriate initial antibiotic use in the entire study population to be 27.36%, as shown by the fact that the value in the SRP group was fourfold higher than that of the NRP group (p Z 0.0004). Initial treatment with an inappropriate antibiotic was independently associated with SRP, with the OR value for this variable adjusted to 8.338 by multivariate logistic regression analysis (Table 3) .
Treatment with an inappropriate antibiotic is very important because it is the only SRP risk factor that can be modified to reduce SRP and improve patient outcomes. 29 The initial selection of an antimicrobial regimen for pneumonia must be guided by consideration of the local microbial ecology and the type of pneumonia to ensure effective antibiotic therapy. 30 There were no differences in the bacterial species and drug susceptibility testing present in the SRP and NRP groups; however, multiple drug resistance (MDR) bacteria appeared at a higher rate in the SRP group (59.09%). Some studies have suggested that both the bacterial species and possible drug resistance should be taken into account when choosing the antibiotic therapy for patients who are likely to be infected with MDR pathogens (including methicillin-resistant Staphylococcus aureus, MRSA). 31, 32 It is better to identify the bacterial distribution Figure 2 . The survival functions of the two groups. The 28-day mortality rate was higher in the slowly resolving pneumonia (SRP) group than the normally resolving pneumonia (NRP) group, but this difference was not statistically significant (p Z 0.10). By contrast, the 60-day mortality rate was significantly higher in the SRP group than the NRP group (p Z 0.02).
The gap between the two lines illustrates the relationship between the length of the intensive care unit (ICU) stay and the mortality rate in the two groups.
and drug resistance in the ICU before choosing the proper initial antibiotic therapy. Different studies debate the use of steroids in pneumonia. Some studies found that corticosteroids exhibit anti-inflammatory effects in severe pneumonia and enable the rapid resolution of pneumonia. 33, 34 Other studies suggested that steroids have adverse effects such as infection and neuromuscular disease, which could delay pneumonia resolution and increase mortality despite the use of an appropriate antibiotic. 35 In our study, in some patients the pneumonia induced acute respiratory distress syndrome, which required the administration of steroids to improve oxygenation. Our study suggested that the administration of high-dose steroids was related to SRP [relative risk (RR) 1.8462, 95% CI 1.5359e2.2191, p Z 0.0053]. However, further investigation showed that the administration of high-dose steroids was not an independent risk factor for SRP, possibly because the sample size receiving high-dose steroids was too small for a valid statistical analysis.
Our study has some limitations. First, this was a singlecenter and retrospective study. A further prospective randomized comparative study is warranted to prove that the identification of high-risk patients can improve their treatment outcomes. Because this was a retrospective study, we had to analyze past information instead of adding more tests to identify the pathogen. Second, some of the trends observed might have reached statistical significance if the study sample size had been larger. Third, the average age of our population was 70.56 AE 12.60 years, preventing our results from properly reflecting the impact of age on SRP.
In conclusion, SRP in critically ill patients should receive more attention because of its high incidence, prolonged ICU stays, and poor outcome. Treatment with an inappropriate antibiotic, multilobar infiltration and a high CURB-65 score were independent risk factors for SRP. The use of appropriate antibiotics in high-risk patients should be taken into account to reduce the prevalence of SRP in the ICU.
